Security key
92764N102
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)
CUSIP: 92764N102
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 168,432,200
- Total 13F shares
- 37,861,951
- Share change
- -225,215
- Total reported value
- $1,297,525,769
- Put/Call ratio
- 89%
- Price per share
- $34.27
- Number of holders
- 61
- Value change
- -$4,041,452
- Number of buys
- 42
- Number of sells
- 16
Report period
Q1 2020
Institutions
61
Top holders
10
VIR full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92764N102
Recent filing periods:
Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
13%
|
22,616,666
|
$284,405,000 | — | 31 Dec 2019 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
3.3%
|
5,499,999
|
$69,162,000 | — | 31 Dec 2019 | |
| ICONIQ Capital, LLC |
13F
|
Company |
2.1%
|
3,583,333
|
$45,042,000 | — | 31 Dec 2019 | |
| Alphabet Inc. |
13F
|
Company |
0.99%
|
1,666,666
|
$20,958,000 | — | 31 Dec 2019 | |
| Capital International Investors |
13F
|
Company |
0.58%
|
983,300
|
$12,365,000 | — | 31 Dec 2019 | |
| INDUS CAPITAL PARTNERS, LLC |
13F
|
Company |
0.4%
|
681,936
|
$8,575,000 | — | 31 Dec 2019 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.3%
|
500,000
|
$6,287,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.16%
|
277,049
|
$3,485,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
169,869
|
$2,136,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
105,752
|
$1,330,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.06%
|
99,741
|
$1,255,000 | — | 31 Dec 2019 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.04%
|
74,898
|
$941,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
40,760
|
$513,000 | — | 31 Dec 2019 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.02%
|
38,905
|
$490,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
35,279
|
$443,000 | — | 31 Dec 2019 | |
| Blackstone Inc. |
13F
|
Company |
0.02%
|
35,000
|
$440,000 | — | 31 Dec 2019 | |
| NORGES BANK |
13F
|
Company |
0.01%
|
25,000
|
$314,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
19,297
|
$243,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
15,466
|
$195,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
15,452
|
$195,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
13,533
|
$170,000 | — | 31 Dec 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
13,234
|
$166,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
12,943
|
$163,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
11,957
|
$150,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.01%
|
11,340
|
$143,000 | — | 31 Dec 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
11,005
|
$138,000 | — | 31 Dec 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
8,200
|
$103,000 | — | 31 Dec 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
4,512
|
$57,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
2,811
|
$34,000 | — | 31 Dec 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,908
|
$24,000 | — | 31 Dec 2019 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,900
|
$23,000 | — | 31 Dec 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,482
|
$19,000 | — | 31 Dec 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,445
|
$18,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,113
|
$14,000 | — | 31 Dec 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
905
|
$11,000 | — | 31 Dec 2019 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
620
|
$8,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
587
|
$7,000 | — | 31 Dec 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
503
|
$6,000 | — | 31 Dec 2019 |
Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q1 2020
As of 31 Mar 2020,
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,861,951 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, Temasek Holdings (Private) Ltd, ICONIQ Capital, LLC, Alphabet Inc., Alaska Permanent Fund Corp, Capital International Investors, BlackRock Inc., EcoR1 Capital, LLC, VANGUARD GROUP INC, and BAILLIE GIFFORD & CO.
This page lists
61
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
38
Q1 2020 holders
61
Holder diff
23
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.